NMPA最新批准多款新药上市,包括信达生物、绿叶制药、恒瑞医药、正大天晴、和黄医药等公司的产品,涉及肥胖、精神分裂症、斑秃、软组织肉瘤、非小细胞肺癌等疾病治疗。
Source LinkNMPA最新批准多款新药上市,包括信达生物、绿叶制药、恒瑞医药、正大天晴、和黄医药等公司的产品,涉及肥胖、精神分裂症、斑秃、软组织肉瘤、非小细胞肺癌等疾病治疗。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.